HANNAH AMMON: Open Payments
NPI 1922719798 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,353 in 188 payments from 19 companies in 2025. Trend: 2023 $218 · 2024 $2,437 · 2025 $3,353
Food & beverage: $3,268Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $385 |
| GENZYME CORPORATION | 9 | $347 |
| ABBVIE INC. | 20 | $323 |
| UCB, Inc. | 13 | $308 |
| MAYNE PHARMA COMMERCIAL LLC | 29 | $274 |
| Organon LLC | 13 | $273 |
| PFIZER INC. | 27 | $264 |
| E.R. Squibb & Sons, L.L.C. | 10 | $233 |
| Regeneron Healthcare Solutions, Inc. | 6 | $212 |
| Galderma Laboratories, L.P. | 17 | $179 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, CIBINQO, Sotyktu, OPZELURA, VTAMA.
Industry payments across OH — which companies pay providers there.
